SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001479290-19-000024
Filing Date
2019-02-26
Accepted
2019-02-26 16:10:00
Documents
3
Period of Report
2019-02-26
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K rvnc22620198k.htm 8-K 26638
2 EXHIBIT 99.1 rvnc2262019exhibit991.htm EX-99.1 147936
3 newlogotaglinea01.jpg GRAPHIC 29677
  Complete submission text file 0001479290-19-000024.txt   216608
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 19633461
SIC: 2834 Pharmaceutical Preparations